Petra Pharma is a clinical-stage pharmaceutical company dedicated to developing novel therapies for serious medical conditions such as cancer and metabolic diseases. Founded in 2016 and based in New York, USA, Petra Pharma focuses on targeting essential cellular processes, including cell division, growth, trafficking, and signaling, through unique enzyme targets. The company's innovative approach involves the development of small molecules aimed at addressing these cellular processes to have a therapeutic impact on human health. Petra Pharma recently secured a $27.55M Debt Financing investment on 15 April 2020. With its pioneering efforts and strategic focus, Petra Pharma presents a compelling opportunity for potential venture capital interest.
Petra Pharma
Pioneering novel therapies to address cancer and metabolic disorders by targeting essential cellular processes, established in 2016 and based in New York.
General Information
BounceWatch is an independent company data service, not affiliated with Petra Pharma. To contact Petra Pharma, visit petrapharmacorp.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Petra Pharma compare?
A PDF of Petra Pharma and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Petra Pharma soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Petra Pharma on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
About Petra Pharma
Business keywords: Pharmaceuticals, Therapeutics, Cancer Treatment, Metabolic Disorders, Cellular Processes, Enzyme Targets, Small Molecules, Clinical-Stage, New York, Innovative Therapies, Drug Development, Medical Research, Healthcare Innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | $27.55M | - |
|
15 Apr 2020 |
| Series A | $48.00M | 10 |
|
06 Jan 2016 |
Petra Pharma Alternatives & Competitors
View All Alternatives
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...
Making cell therapies more durable and effective through metabolic reprograming.
DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS
FAQ About Petra Pharma
Source: BounceWatch company record for Petra Pharma, https://bouncewatch.com/company/petra-pharma, updated 27 December 2024. When citing, please name BounceWatch and link this page.
